선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Nucor Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $53.5B | |
|---|---|---|
| Revenue (ttm) | 38.8B | |
| Net income (ttm) | 3.6B | |
| EPS (ttm) | $15.7 | |
| Shares out | 226.9M | |
| P/E (trailing) | 17.3x | |
| P/E (forward) | 11.4x | |
| Dividend | $2.24 (0.83%) | |
| Volume | 1,659,243 | |
| Beta | 1.85 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $36.48B | $41.51B | $34.71B | $30.73B | $32.49B | -2.9% |
| Gross profit | $3.46B | $2.00B | $1.39B | $627.0M | $3.88B | +2.9% |
| Operating income | $9.36B | $10.51B | $6.52B | $3.13B | $2.63B | -27.2% |
| Net income | $6.83B | $7.61B | $4.53B | $2.03B | $1.74B | -28.9% |
| EPS (diluted) | $23.16 | $28.79 | $18.00 | $8.46 | $7.52 | -24.5% |
| EBITDA | $10.23B | $11.57B | $7.69B | $4.49B | $4.11B | -20.4% |
| R&D | — | — | — | — | — | — |
| SG&A | $1.71B | $2.00B | $1.59B | $1.12B | $1.22B | -8.1% |
Recent company headlines from major financial publishers.
The base case represents the modal expected cyclical recovery path synthesized across forward earnings, multi-stage moat fade, owner earnings, and FCFF DCF models. Consolidated revenue recovers 24.63% in FY2026 to $40.50B before decelerating toward long-term nominal economic growth of 2.0% to 2.5%. Operating margins rebound to 13.50% in FY2026 and normalize to 10.00% by FY2030, in line with mid-cycle historical averages and direct mini-mill peer STLD (11.50%). Capital expenditures step down from peak transformation intensity of $3,422M in FY2025, restoring annual free cash flow above $2.5B.
Accelerated commercial ramp of the West Virginia sheet mill and persistent margin expansion driven by captive DRI cost advantages and record downstream backlogs drive fundamental intrinsic value toward the upper valuation boundary. Operating margins expand beyond 12.5% as non-residential construction and federal infrastructure spending sustain consolidated revenue above $40B, and capital expenditures normalize toward $2.0B, unlocking over $3.5B in free cash flow and accelerating counter-cyclical share repurchases.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 10.4% | $161 | $163 | $165 | $168 | $170 |
| 10.9% | $155 | $156 | $158 | $160 | $162 |
| 11.4% | $149 | $150 | $154 | $154 | $156 |
| 11.9% | $143 | $145 | $146 | $148 | $149 |
| 12.4% | $139 | $140 | $141 | $142 | $144 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |